A longitudinal study of the relationship between galactosylation degree of IgG and rheumatoid factor titer and avidity during long-term immunization of rabbits with BSA

References

• Haberman AM, William J, Euler Ch, Schlomchik MJ. Rheumatoid factors in health and disease: Structure, function, induction and regulation. Curr Dir Autoimmun 2003; 6: 169–195
   PubMedGoogle Scholar
• Devey ME, Hogben DN. Rheumatoid factor and immune complexes. Monogr Allergy 1989; 26: 230–239
   PubMedGoogle Scholar
• Vaughan JH. Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis Rheum 1993; 36: 1–6
   PubMedGoogle Scholar
• Newkirk MM, Novick J, Stevenson MM, Fournier M-J, Apostolakos P. Differential clearance of glycoforms of IgG in normal and autoimmune-prone mice. Clin Exp Immunol 1996; 106: 259–264
   PubMed Web of Science ®Google Scholar
• Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 452–457
   PubMed Web of Science ®Google Scholar
• Leader KA, Lastra GC, Kirwan JR, Elson CJ. Agalactosyl IgG in aggregates from the rheumatoid joint. Br J Rheumatol 1996; 35: 335–341
   PubMedGoogle Scholar
• Newkirk MM, Fournier M-J, Shiroky J. Rheumatoid factor avidity in patients with rheumatoid arthritis: Identification of pathogenic RFs which correlate with disease parameters and with the Gal(0) glycoform of IgG. J Clin Immunol 1995; 15: 250–257
   PubMedGoogle Scholar
• Soltys AJ, Hay FC, Bond A, Axford JS, Jones MG, Randen I, Thompson KM, Natvig JB. The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand J Immunol 1994; 40: 135–143
   PubMed Web of Science ®Google Scholar
• Rademacher TW. Network theory of glycosylation—etiologic and pathogenic implications of changes in IgG glycoform levels in autoimmunity. Semin Cell Biol 1991; 2: 327–337
   PubMedGoogle Scholar
• Lastra GC, Thompson SJ, Lemonidis AS, Elson ChJ. Changes in the galactose content of IgG during humoral immune responses. Autoimmunity 1998; 28: 25–30
   PubMed Web of Science ®Google Scholar
• Bodman KB, Hutchings PR, Jeddi PA, Delves PJ, Rook GAW, Sumar N. IgG glycosylation in autoimmune-prone mice. Clin Exp Immunol 1994; 95: 103–107
   PubMed Web of Science ®Google Scholar
• Stanley SL, Bischoff JK, Davie JM. Antigen-induced rheumatoid factors. Protein and carbohydrate antigens induce different rheumatoid factor responses. J Immunol 1987; 139: 2936–2941
   PubMed Web of Science ®Google Scholar
• Nezlin R. The immunoglobulins, structure and function. Chap 2. Animal and human immunoglobulins. Academic Press, San Diego 1998; 75–121
   Google Scholar
• Kim B, Behbahani I, Meyerhoff ME. Lectin-based homogenous Enzyme-linked binding assay for estimating the type and relative amount of carbohydrate within intact glycoproteins. Annal Biochem 1992; 202: 166–171
   PubMedGoogle Scholar
• Lurhuma AZ, Cambiaso CL, Masson PL, Heremans JF. Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatoid factor or C1q. Clin Exp Immunol 1976; 25: 212–226
   PubMed Web of Science ®Google Scholar
• Keusch J, Levy Y, Shoenfeld Y, Youinou P. Analysis of different glycosylation sites in IgG subclasses. Clin Chim Acta 1996; 252: 147–158
   PubMedGoogle Scholar
• Alavi A, Axford JS. The glycosyltransferases. Abnormalities of IgG glycosylation and immunological disorders, DA Isenberg, TW Rademacher. John Wiley & Sons, Chichester 1996; 149–169
   Google Scholar
• Thompson SJ, Leader KA, Lastra GC, Elson ChJ. The role of agalactosyl IgG in rodent models of autoimmune disease and in pathogenesis of rheumatoid arthritis. Abnormalities of IgG glycosylation and immunological disorders, DA Isenberg, TW Rademacher. John Wiley & Sons, Chichester 1996; 131–148
   Google Scholar
• Jefferis R, Lund J, Pound JD. IgG-Fc-mediated effector functions: Molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol Rev 1998; 163: 59–76
   PubMed Web of Science ®Google Scholar
• De Vos Cloetens Ch, Minsart-Baleriaux V, Urbain-Vansanten G. Possible relationship between antibodies and non-specific immunoglobulins simultaneously induced after antigen stimulation. Immunology 1971; 20: 955–962
   PubMedGoogle Scholar
• Rademacher TW, Jones RHV, Williams PhJ. Immunoglobulins carry infectious non-self mimetic carbohydrate residues. Implications for the function of antibodies in health and disease. Abnormalities of IgG glycosylation and immunological disorders, DA Isenberg, TW Rademacher. John Wiley & Sons, Chichester 1996; 221–252
   Google Scholar
• Jefferis R, Magged RA. The specificity and reactivity of rheumatoid factors with human IgG. Monogr Allergy 1989; 26: 45–60
   PubMedGoogle Scholar
• Sinclair NRStC, Panoskaltsis A. Immunoregulation by Fc signals—A mechanism for self-nonself discrimination. Immunol Today 1987; 8: 76–79
   PubMedGoogle Scholar
• Murray J, Brown JC. Hyperimmunization alters Fcγ antigenicity. J Immunol 1988; 141: 2668–2673
   PubMedGoogle Scholar
• Kenny TP, Leider P, Duong P-A, Robbins DL. Antigen binding differences between secreted and cell surface expressed rheumatoid factor derived from inflamed synovium. J Rheumatol 1996; 23: 819–825
   PubMedGoogle Scholar
• Bond A, Cooke A, Hay FC. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Eur J Immunol 1990; 20: 2229–2233
   PubMed Web of Science ®Google Scholar
• Milošević-Jovčić N, Ćirić D, Hajduković-Dragojlović Lj, Mirčetić V. Differences in the relationship of specificity to titer and functional affinity between circulating Ga- and pan-reactive IgM rheumatoid factors in rheumatoid arthritis. Rheumatology 2004; 43: 1190–1193
   PubMedGoogle Scholar